McKesson — Nov 6, 2024 release

Tyler continued, "As a result of our first half performance and continued confidence across the enterprise over the remainder of the fiscal year, we are raising and narrowing our guidance range for fiscal 2025 Adjusted Earnings per Diluted Share to $32.40 to $33.00. We remain confident in our ability to deliver against our fiscal 2025 outlook, which is above the long-term targets we have previously provided." Fiscal 2025 Second Quarter Result Summary Second Quarter Year-to-Date ($ in millions, except per share amounts) FY25 FY24 Change FY25 FY24 Change Revenues $ 93,651  $ 77,215  21  % $ 172,934  $ 151,698  14  % Net income attributable to McKesson Corporation 241  664  (64) 1,156  1,622  (29) Adjusted Earnings 2 915  841  9  1,944  1,834  6  Earnings per diluted common share attributable to McKesson Corporation 1.87  4.92  (62) 8.89  11.95  (26) Adjusted Earnings per Diluted Share 2 7.07  6.23  13  14.95  13.51  11  1 See below under "Fiscal 2025 Outlook" for full explanation 2 Adjusted results in this earnings release are non-GAAP financial measures; refer to the accompanying definitions and reconciliation schedules Second quarter revenues were $93.7 billion, an increase of 21% from a year ago, primarily driven by growth in the U.S. Pharmaceutical segment, which includes onboarding a new strategic partner and increased prescription volumes, including higher volumes from retail national account customers, specialty products, and GLP-1 medi